Protagonist Therapeutics Inc buy Truist Financial Co.
Start price
11.03.25
/
50%
€50.50
Target price
11.03.26
€70.01
Performance (%)
66.34%
End price
12.03.26
€84.00
Summary
This prediction ended on 12.03.26 with a price of €84.00. With a performance of 66.34% the BUY prediction by Truist_Financial_Co_ was a big success. Truist_Financial_Co_ has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 2.564% | 2.564% | 151.046% |
| iShares Core DAX® | 3,15 % | 1,50 % | 9,13 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % | 28,64 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % | 53,03 % |
| iShares S&P 500 | 4,58 % | 1,92 % | 23,97 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at Truist Financial Co. from $60.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€75.49
28.10.26
28.10.26
81.82%
05.08.26
05.08.26
Stopped prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
09.09.24
09.09.24
€54.34
09.09.25
09.09.25
4.95%
10.09.25
10.09.25